Synopsis of recent research by authors named "Pralay Mukhopadhyay"
- Pralay Mukhopadhyay's recent research focuses predominantly on statistical methodologies and clinical trial designs in the field of immuno-oncology, particularly regarding survival analysis and treatment efficacy assessment for patients with various cancers.
- His work includes a systematic review comparing traditional log-rank tests with the MaxCombo test for analyzing survival data under nonproportional hazards, highlighting the limitations of standard methodologies in capturing treatment benefits in novel immunotherapy scenarios.
- Additionally, Mukhopadhyay's studies investigate the predictive value of biomarkers, such as PD-L1 expression and liver metastases, in evaluating treatment outcomes and optimizing safety profiles in immuno-oncology trials, establishing new standard care protocols and improving overall survival metrics in patients with advanced cancers.
